000 01456 a2200397 4500
005 20250513191806.0
264 0 _c19991020
008 199910s 0 0 eng d
022 _a1079-2104
024 7 _a10.1016/s1079-2104(99)70124-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAguirre, J M
245 0 0 _aReduction of HIV-associated oral lesions after highly active antiretroviral therapy.
_h[electronic resource]
260 _bOral surgery, oral medicine, oral pathology, oral radiology, and endodontics
_cAug 1999
300 _a114-5 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAIDS-Related Opportunistic Infections
_xprevention & control
650 0 4 _aAdult
650 0 4 _aAnti-HIV Agents
_xtherapeutic use
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aFemale
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV Protease Inhibitors
_xtherapeutic use
650 0 4 _aHIV-1
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMouth Diseases
_xprevention & control
650 0 4 _aReverse Transcriptase Inhibitors
_xtherapeutic use
650 0 4 _aViral Load
700 1 _aEchebarria, M A
700 1 _aOcina, E
700 1 _aRibacoba, L
700 1 _aMontejo, M
773 0 _tOral surgery, oral medicine, oral pathology, oral radiology, and endodontics
_gvol. 88
_gno. 2
_gp. 114-5
856 4 0 _uhttps://doi.org/10.1016/s1079-2104(99)70124-1
_zAvailable from publisher's website
999 _c10425971
_d10425971